To make an appointment, please call 1-800-KARMANOS (1-800-527-6266) or request an appointment online
As a leader in cancer research, Karmanos is able to offer patients access to innovative treatments and clinical trials that are often times not available anywhere else.
To offer hope and longer life to patients with all types of cancer, Karmanos offers the latest types of therapy through our clinical trials program. Through clinical trials, we are creating new knowledge about how therapies fight cancer and provide national leadership in testing these new therapies.
We understand that cancer is a complex disease that demands complex care. We provide each patient with a dynamic, carefully constructed treatment plan focused on their specific cancer and their unique needs.
We listen to you to design a plan that provides you with respect, compassionate care and is responsive to your emotional and practical concerns.
Hour Detroit’s 2024 Top Docs List is out; over 50 physicians from the Barbara Ann Karmanos Cancer Institute are listed. Each year, Hour Detroit Magazine puts out an online peer-to-peer review survey conducted by Professional Research Services (PRS) to determine the top physicians in southeastern Michigan. Participating physicians in Livingston, Macomb, Oakland, Washtenaw, and Wayne Counties nominate the best doctors in each field. This year’s list also includes a feature with Elisabeth...
The Barbara Ann Karmanos Cancer Institute’s fourth annual Prostate Cancer Awareness Night with the Detroit Tigers and McLaren Health Care, the official health care system of the Tigers, was a home run on Monday, July 8. Hundreds of prostate cancer survivors and their loved ones were brought together under the lights of Comerica Park as the Detroit Tigers beat their division rival, the Cleveland Guardians. This awareness game also provided crucial information on early detection, highlighted the importanc...
Radiopharmaceutical therapy (RPT) is a revolutionary treatment that targets metastasized tumors at the cellular level, reducing radiation exposure to normal, healthy tissue and reducing significant side effects – a possibility that occurs with conventional external radiation therapies. “RPT uses radioisotope therapy in the process of delivering the radiation intravenously to cancer cells by adding radioactive material, or radionuclides, to proteins that bind with the receptors on the cancer cells, destr...